Mr. Niels Smedegaard Andersen MD
Hematologist-Oncologist | Hematology & Oncology
825 Eastlake Ave E Seattle WA, 98109About
Dr. Niels Andersen is a hematologist oncologist practicing in Seattle, WA. Dr. Andersen specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Real-time polymerase chain reaction estimation of bone marrow tumor burden using clonal immunoglobulin heavy chain gene and bcl-1/JH rearrangements in mantle cell lymphoma.
- Primary treatment with autologous stem cell transplantation in mantle cell lymphoma: outcome related to remission pretransplant.
- Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo-purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group.
- Pre-emptive treatment with rituximab of molecular relapse after autologous stem cell transplantation in mantle cell lymphoma.
- Single-institution long-term outcomes for patients receiving nonmyeloablative conditioning hematopoeitic cell transplantation for chronic lymphocytic leukemia and follicular lymphoma.
- Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC + autologous stem-cell support: still very long survival but late relapses do occur.
- Outcomes of Cord Blood Transplantation Using Reduced-Intensity Conditioning for Chronic Lymphocytic Leukemia: A Study on Behalf of Eurocord and Cord Blood Committee of Cellular Therapy and Immunobiology Working Party, Chronic Malignancies Working Par
- 15-year follow-up of the Second Nordic Mantle Cell Lymphoma trial (MCL2): prolonged remissions without survival plateau.
- Early Natural Killer Cell Reconstitution Predicts Overall Survival in T Cell-Replete Allogeneic Hematopoietic Stem Cell Transplantation.
- Molecular Monitoring after Autologous Stem Cell Transplantation and Preemptive Rituximab Treatment of Molecular Relapse; Results from the Nordic Mantle Cell Lymphoma Studies (MCL2 and MCL3) with Median Follow-Up of 8.5 Years.
- Centre characteristics and procedure-related factors have an impact on outcomes
- Baseline Characteristics Predicting Very Good Outcome of Allogeneic Hematopoietic Cell Transplantation in Young Patients With High Cytogenetic Risk Chronic Lymphocytic Leukemia - A Retrospective Analysis From the Chronic Malignancies Working Party of
- C-Reactive Protein Levels at Diagnosis of Acute Graft-versus-Host Disease Predict Steroid-Refractory Disease, Treatment-Related Mortality, and Overall Survival after Allogeneic Hematopoietic Stem Cell Transplantation.
Mr. Niels Smedegaard Andersen MD's Practice location
Mr. Niels Smedegaard Andersen MD's reviews
Write ReviewRecommended Articles
- Dance Mom Abby Lee Miller Diagnosed with Non-Hodgkin Lymphoma
Abby Lee Miller, known for her brutal dance instruction and demanding style of training, is as recognized for her tirades as she is for her long-running hit reality show Dance Moms.Abby inherited the love of dance from her late mother and started her own dance company at just 14 years old. She...
- Treatments for Multiple Myeloma
The cancer care crew discusses what treatment will suit you after multiple myeloma has been diagnosed and staged. The following are treatments used in multiple myeloma:...
- Make-A-Wish Makes a Movie Star
Through their fundraising, on average in the United States and its territories, Make-A-Wish is able to grant the wish of a child every 34 minutes.How was it started?The Make-A-Wish Foundation started with the wish of one 7-year-old boy’s wish in 1980. Chris Grecius, who had leukemia, wanted to be...
- Treatment Update for Hodgkin Lymphoma
Over time, research has uncovered ways of treating Hodgkin lymphoma (HL) to produce an 80% to 90% cure rate. For the remaining 10% to 20% who are either resistant to the primary treatment or have relapsed, their cancer can still be fatal.The standard care for those not yet cured has been a two-step...
- Teen with Hodgkin Lymphoma Skates with Her Hero, Mario Lemieux
Lillian Tarasiewicz was diagnosed with stage 3B Hodgkin lymphoma in October of 2015. She currently resides in South Carolina, but because of her father’s Pennsylvania background, she grew up with a love for hockey and for the Pittsburgh Penguins. She always felt a special connection to Mario...
- Treatment Options of Multiple Myeloma
A team led by a consultant haematology specialist takes care of you if you are a multiple myeloma patient. The team discusses your situation and suggests the best treatment for you, but you will finally decide.It may be paramount to compile a list of questions which you will ask the specialist...
Nearby Providers
- Dr. Nicole Kuderer M.D.825 Eastlake Ave E Seattle WA 98109
- Dr. Sharmila Ahmed MD1101 MADISON ST SEATTLE WA 98104
- Dr. Sheldon Z Goldberg MD515 Minor Ave Seattle WA 98104
- Dr. Elena G Chiorean M.D.825 EASTLAKE AVE E SEATTLE WA 98109
- Dr. Vincent J Picozzi MD1100 9th Ave Seattle WA 98101
- Dr. J samuel Tolman M.D.1560 N 115th St Seattle WA 98133